Kelly, C. M., Banerjee, M., Roemeling, R. V., Ho, A. L., Banks, L. B., Chi, P., Clark, C., Keohan, M. L., Maki, R. G., Movva, S., Schroeder, K., Lefkowitz, R. A., Qin, L., Wong, P., Middya, S., Shrivastava, R., Chakraborty, D., Surya, A., Tap, W. D., D'Angelo, S. P. (2026). Systemic third generation allosteric STING agonist CRD3874-SI, a novel immunotherapy, in patients with advanced solid tumors: Results from a single-agent phase I study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2661